Home » Topics » Regulatory

Regulatory
RSS

Ranitidine shows no benefit in psoriasis

Sep. 2, 1997

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Famotidine for schizophrenia

Sep. 1, 1997

FDA clears new formulation of Imitrex

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

New indication approved for Asacol

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...